This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled “Caution Concerning Forward-Looking Statements” later in this news release. MONTRÉAL, Nov. 2, 2023 /PRNewswire/ – BCE Inc. (BCE) today announced that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by BCE… Continue reading BCE announces renewal of Normal Course Issuer Bid for Preferred Shares
Category: Newswire
ESTO Holdings OU reports record-breaking third quarter 2023 results underlining market leader positioning in the Baltics and announces upcoming equity raise
TALLINN, Estonia, Nov. 2, 2023 /PRNewswire/ — ESTO Holdings OU, a leading Estonian payment processor and consumer credit provider, today reported its all-time high financial results for the three-quarters of 2023. With revenue growth of 54% from a year ago, the company has achieved a historic milestone by attaining a three consecutive quarter profit of EUR 2.3mln, confirming… Continue reading ESTO Holdings OU reports record-breaking third quarter 2023 results underlining market leader positioning in the Baltics and announces upcoming equity raise
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023
The disease control rate for subjects in the monotherapy was 93% for patients who received at least one dose of INT230-6 INT230-6 extended survival in refractory soft tissue sarcoma subjects by nearly 15 months when compared to a synthetic control group In the study, INT230-6 was found to have a favorable safety profile and be… Continue reading Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023
Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
In a total of 26 ibezapolstat-treated patients in Phases 2a and 2b, the Clinical Cure rate is 96% Meets protocol primary objective of assessing the primary efficacy endpoint of the Clinical Cure rate after 10 days of oral treatment Ibezapolstat was well tolerated; no drug-related Serious Adverse Events Further analyses forthcoming regarding secondary and exploratory endpoints, including Sustained… Continue reading Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
Daily Harvest Introduces Pasta That Feels Like a Party
Live it up in your living room with new primavera, bolognese and pesto dishes NEW YORK, Nov. 2, 2023 /PRNewswire/ — Daily Harvest, the company on a mission to make it easy to eat more sustainably-grown fruits and vegetables, today announced a new collection of gluten-free pasta dishes that are packed with saucy veggies and… Continue reading Daily Harvest Introduces Pasta That Feels Like a Party
Hydrosat Awards Contract to Muon Space to Integrate Proprietary Multispectral and Thermal Infrared (IR) Imaging Instrument for2024 Satellite Launch
WASHINGTON, Nov. 2, 2023 /PRNewswire/ — Hydrosat, the climate tech company that specializes in delivering satellite imagery and data analytics to measure water stress and climate impact, announced today a partnership with Muon Space, a climate satellite company revolutionizing the way Earth is monitored from space. Muon Space has been awarded a Hydrosat contract for… Continue reading Hydrosat Awards Contract to Muon Space to Integrate Proprietary Multispectral and Thermal Infrared (IR) Imaging Instrument for2024 Satellite Launch
OGE Energy Corp. reports third quarter 2023 results
OKLAHOMA CITY, Nov. 2, 2023 /PRNewswire/ — OGE Energy Corp. (NYSE: OGE), the parent company of Oklahoma Gas and Electric Company (“OG&E”), today reported earnings of $1.20 per diluted share during the three months that ended September 30, 2023, compared to $1.31 per diluted share in the same period of 2022. Earnings for the third… Continue reading OGE Energy Corp. reports third quarter 2023 results
Nuvei and American Express join forces to facilitate seamless account-to-account payments between merchants and their customers
Nuvei’s UK merchants can now integrate Pay with Bank Transfer to meet customer demand for seamless and secure instant payments MONTREAL, Nov. 2, 2023 /PRNewswire/ — Pay with Bank transfer, powered by American Express (“PwBt”), announces it has selected Nuvei Corporation (“Nuvei”) (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, as its first acquirer authorised… Continue reading Nuvei and American Express join forces to facilitate seamless account-to-account payments between merchants and their customers
MEDGENE’S RHDV2 VACCINE GRANTED CRITICAL LICENSE BY USDA’S CENTER FOR VETERINARY BIOLOGICS
The vaccine targeting the lethal Rabbit Hemorrhagic Disease has successfully passed required efficacy and duration-of-immunity tests BROOKINGS, S.D., Nov. 2, 2023 /PRNewswire/ — Medgene, an animal health company that produces highly-targeted platform vaccines, has been granted a Conditional Use License by the United States Department of Agriculture’s Center for Veterinary Biologics (USDA-CVB) to further manufacture and… Continue reading MEDGENE’S RHDV2 VACCINE GRANTED CRITICAL LICENSE BY USDA’S CENTER FOR VETERINARY BIOLOGICS
aptihealth’s Dr. Kevin Martin, Selected as 2023 CDPHP Capital Region Top Doctors Peabody Award Winner
SARATOGA SPRINGS, N.Y., Nov. 2, 2023 /PRNewswire/ — aptihealth is thrilled to announce that our Chief Psychiatric Officer, Dr. Kevin Martin, has been awarded the 2023 Top Doctors Peabody Award by CDPHP. This prestigious award highlights Dr. Martin’s exceptional contributions to the field of behavioral healthcare and his unwavering commitment to improving the lives of… Continue reading aptihealth’s Dr. Kevin Martin, Selected as 2023 CDPHP Capital Region Top Doctors Peabody Award Winner